IRIS
CUOMO, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.666
EU - Europa 1.629
NA - Nord America 1.416
SA - Sud America 175
Continente sconosciuto - Info sul continente non disponibili 79
AF - Africa 66
OC - Oceania 3
Totale 5.034
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.354
IT - Italia 688
SG - Singapore 664
RU - Federazione Russa 480
VN - Vietnam 385
CN - Cina 290
BR - Brasile 132
DE - Germania 121
HK - Hong Kong 101
FR - Francia 83
JP - Giappone 51
NL - Olanda 43
CA - Canada 38
GB - Regno Unito 38
IN - India 34
FI - Finlandia 33
BD - Bangladesh 27
PT - Portogallo 21
ES - Italia 18
AR - Argentina 17
ZA - Sudafrica 17
PH - Filippine 16
KR - Corea 15
PL - Polonia 15
CI - Costa d'Avorio 13
AT - Austria 12
LT - Lituania 12
CO - Colombia 10
IQ - Iraq 10
MX - Messico 10
UA - Ucraina 10
EG - Egitto 9
PK - Pakistan 9
TR - Turchia 9
BE - Belgio 8
IE - Irlanda 8
MA - Marocco 8
ID - Indonesia 7
KE - Kenya 6
SE - Svezia 6
TH - Thailandia 6
TW - Taiwan 6
VE - Venezuela 6
CZ - Repubblica Ceca 5
GE - Georgia 5
HR - Croazia 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
JM - Giamaica 4
JO - Giordania 4
MY - Malesia 4
RO - Romania 4
UZ - Uzbekistan 4
CH - Svizzera 3
RS - Serbia 3
TN - Tunisia 3
AU - Australia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BJ - Benin 2
CL - Cile 2
CR - Costa Rica 2
DZ - Algeria 2
GR - Grecia 2
HN - Honduras 2
IL - Israele 2
LV - Lettonia 2
NO - Norvegia 2
PA - Panama 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
CY - Cipro 1
DM - Dominica 1
ET - Etiopia 1
GF - Guiana Francese 1
GY - Guiana 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
MD - Moldavia 1
MM - Myanmar 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PY - Paraguay 1
SA - Arabia Saudita 1
SD - Sudan 1
SR - Suriname 1
SY - Repubblica araba siriana 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
YT - Mayotte 1
Totale 4.956
Salva come PNG Salva come JPEG
Città #
Singapore 326
San Jose 275
Ashburn 174
Moscow 128
Chandler 116
Naples 110
Ho Chi Minh City 104
Hong Kong 95
Hanoi 86
Hefei 84
Beijing 76
Council Bluffs 75
Santa Clara 52
Lauterbourg 40
Los Angeles 36
Munich 35
Milan 31
Rome 31
Tokyo 29
Dallas 23
New York 23
Palermo 22
Buffalo 21
Frankfurt am Main 21
Millbury 21
Amsterdam 20
Lawrence 19
Bologna 18
The Dalles 18
São Paulo 17
Haiphong 16
Seattle 16
Da Nang 15
Seoul 15
Napoli 14
Toronto 13
Turin 13
Boston 12
Caserta 12
Des Moines 12
Helsinki 12
Houston 11
Lappeenranta 11
London 11
Florence 10
Montijo 10
Orem 10
Redondo Beach 10
Bari 9
Nanjing 9
Sennori 9
Wilmington 9
Bogotá 8
Manfredonia 8
Montreal 8
Phoenix 8
Biên Hòa 7
Brescia 7
Brooklyn 7
Chennai 7
Denver 7
Düsseldorf 7
Falkenstein 7
Hải Dương 7
Johannesburg 7
Kochi 7
Nuremberg 7
Turku 7
Woodbridge 7
Atlanta 6
Catania 6
Chicago 6
Foggia 6
Madrid 6
Nha Trang 6
Padova 6
Warsaw 6
Cagliari 5
Can Tho 5
Castelcovati 5
Chengdu 5
Collecchio 5
Roubaix 5
Thái Bình 5
Vienna 5
Wroclaw 5
Belo Horizonte 4
Bến Tre 4
Cologne 4
Dong Ket 4
Dublin 4
Fairfield 4
Guangzhou 4
Karachi 4
Kingston 4
Locorotondo 4
Mexico City 4
Nairobi 4
Oeiras 4
Olomouc 4
Totale 2.657
Salva come PNG Salva come JPEG
Nome #
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice 750
Meccanismi molecolari della cardiotossicità indotta da antracicline e radioterapia 205
Evaluation of exercise capacity by means of cardiopulmonary exercise testing (CPET) in older adult cancer patients undergoing antineoplastic treatments 166
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients 163
Prevention of cardiovascular complications in elderly cancer patients 155
Heart Failure and Cancer: Mechanisms of Old and New Cardiotoxic Drugs in Cancer Patients 152
Oxidative stress in anticancer therapies-related cardiac dysfunction 150
New drugs, therapeutic strategies, and future direction for the treatment of Pulmonary Arterial Hypertension 146
New-Onset Cancer in the HF Population: Epidemiology, Pathophysiology, and Clinical Management 145
What is the cardiac impact of chemotherapy and subsequent radiotherapy in lymphoma patients 144
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications 143
Editorial: Myocardium regeneration and cardioprotection 141
Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment 134
Low-intensity pulsed ultrasound (LIPUS) in heart failure with preserved ejection fraction (HFpEF): lupus in fabula? 134
How can we manage the cardiac toxicity of immune checkpoint inhibitors? 134
Mildly Elevated Pulmonary Hypertension: Gray Zone or Already a Disease? 131
Cardiovascular events and treatment of children with high risk medulloblastoma 130
Redox imbalances in ageing and metabolic alterations: Implications in cancer and cardiac diseases. An overview from the working group of cardiotoxicity and cardioprotection of the Italian society of cardiology (SIC) 128
The broad spectrum of cardiotoxicities from immunotherapies 120
Electrical Storm in Patients with Inappropriate Implantable Cardioverter-Defibrillator Therapy: Current Trends in Clinical Practice between Guidelines and Technology Progress 120
Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF 119
Causes and outcomes of {ICU} hospitalisations in patients with pulmonary arterial hypertension 115
Cardio-Oncology Challenges in Elderly Patients 113
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors 113
Commentary on “Functional Improvement After Outpatient Cardiac Rehabilitation in Acute Coronary Syndrome Patients is not Related to Improvement in Left Ventricular Ejection Fraction” 112
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 110
Prevention of cancer-therapy-related heart failure 105
Pembrolizumab associated hypereosinophilia in locally advanced triple-negative breast cancer 101
Inflammatory Mechanisms in the Pathogenesis of Pulmonary Arterial Hypertension: Recent Advances 89
Risk Stratification of Patients with Pulmonary Arterial Hypertension: The Role of Echocardiography 84
Is it time to update our defibrillation strategies for refractory ventricular fibrillation? 76
Inflammation at the crossroad between cancer and heart failure 65
Virtual reality solution to promote adapted physical activity in older adults: outcomes from VR2Care project exploratory study 58
TAPSE/sPAP Ratio to Improve Risk Assessment in Pulmonary Arterial Hypertension 55
Digital interventions addressing the unmet needs of older adults with multimorbidity: a mixed-methods persona design approach 53
Exploring motivational readiness for adapted physical activity in older adults with chronic illness: patterns of self-care behaviors, engagement, and psychological distress 51
Nonpharmacological management of pulmonary arterial hypertension 37
The Activin Pathway in Chronic Thromboembolic Pulmonary Hypertension: A Potential Biomarker for Residual Pulmonary Hypertension After Endarterectomy 31
Placental growth factor modulates endothelial NO production and exacerbates experimental hepatopulmonary syndrome 19
Exploring the Endothelin-1 pathway in chronic thromboembolic pulmonary hypertension microvasculopathy 16
ERS Congress 2024: highlights from the Pulmonary Vascular Diseases Assembly 16
Understanding self-care behaviors in older adults with chronic diseases: The influence of personal views on aging and illness perceptions 5
Totale 5.034
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.919
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.919
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022138 0 0 0 8 2 5 11 8 3 16 41 44
2022/2023597 21 34 41 46 59 43 45 86 124 53 25 20
2023/2024340 19 20 33 39 22 52 20 42 17 20 32 24
2024/20251.216 49 44 6 28 28 110 109 100 73 113 429 127
2025/20262.444 213 173 277 187 412 85 350 134 280 193 81 59
2026/2027151 62 80 9 0 0 0 0 0 0 0 0 0
Totale 5.034